|
|
|
| home > pmps > autumn 2003 > total supply chain solutions for the life sciences industry |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Let's begin by talking about the core services DHL provides to the life sciences industry.
DHL has been providing logistics solutions for the life sciences industry for many years. However, logistics is playing an ever greater role in this sector as companies seek to get closer to end-users and differentiate products through added value. As a result, in recent years DHL has been actively developing and refining customised services for the entire life sciences supply chain - from distribution consulting and design to management and execution.
Clinical trials, direct distribution programmes and cold chain services are some of the key focus areas for DHL. Our clinical trial services that offer distribution of clinical trial supplies, diagnostic specimen kits and case record forms, as well as the return of diagnostic specimens (using special IATA compliant collection kits) consigned to central laboratories for analysis. The life sciences industry is gradually moving towards various direct distribution models to improve integrity and stability of products in transit, while ensuring compliance, safety and customer satisfaction. DHL therefore has a range of direct distribution programmes for the delivery of pharmaceutical products, reagents and medical devices.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
Prince Helps Sustainable Pharma Packaging Pioneers Woolcool Celebrate 10th Anniversary
Ground-breaking sustainable pharma packaging firm Woolcool celebrated a decade of innovation with a visit by HRH The Prince of Wales.
More info >> |
|
 |
White Papers |
 |
|
Planning the Execution of a Viral Clearance Study
Eurofins BioPharma Product Testing
Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
More info >> |
|
 |
Industry Events |
 |
2020 Avoca Quality and Innovation Summit
3-4 June 2020, Amsterdam, The Netherlands
The 2020 Avoca Quality and Innovation Summit will take place 3-4 June
2020, in Amsterdam, The Netherlands.
More info >> |
|
|
